Professor Mimi Tang is an immunologist allergist with an established international profile in the field of allergic disorders - she is considered a leading expert in food oral immunotherapy. She is Head of the Allergy Immunology Research Group and Director of the Allergy Translation Centre at Murdoch Children’s Research Institute, Professorial Fellow at the University of Melbourne Department of Paediatrics and Consultant Immunologist Allergist at Melbourne's Royal Children’s Hospital. Professor Tang has more than 25 years of experience in the investigation of basic immunological mechanisms underlying allergic disease pathogenesis and more than 15 years of clinical trials experience.
Professor Tang also collaborates on a number of longitudinal cohort studies including the Barwon Infant Study, HealthNuts and SchoolNuts and on the VITALITY clinical trial, and is a key leader within the NHMRC-funded CFAR CRE (Centre for Food and Allergy Research - a collaboration of experts in children’s food allergy and food-related immune disorders.
CFAR uses the latest approaches in epidemiology, immunology, paediatrics, nutrition, gastroenterology and biostatistics to investigate factors that cause, prevent and improve food allergies and aims to eradicate food allergy through improved prevention and cure, supported by evidence generated by a collaborative network of research; additional aim is to improve management of food allergy through public health policy and clinical pathways.
Professor Mimi Tang is an immunologist allergist with an established international profile in the field of allergic disorders - she is considered a leading expert in food oral immunotherapy. She is Head of the Allergy Immunology Research Group and...
Professor Mimi Tang is an immunologist allergist with an established international profile in the field of allergic disorders - she is considered a leading expert in food oral immunotherapy. She is Head of the Allergy Immunology Research Group and Director of the Allergy Translation Centre at Murdoch Children’s Research Institute, Professorial Fellow at the University of Melbourne Department of Paediatrics and Consultant Immunologist Allergist at Melbourne's Royal Children’s Hospital. Professor Tang has more than 25 years of experience in the investigation of basic immunological mechanisms underlying allergic disease pathogenesis and more than 15 years of clinical trials experience.
Professor Tang also collaborates on a number of longitudinal cohort studies including the Barwon Infant Study, HealthNuts and SchoolNuts and on the VITALITY clinical trial, and is a key leader within the NHMRC-funded CFAR CRE (Centre for Food and Allergy Research - a collaboration of experts in children’s food allergy and food-related immune disorders.
CFAR uses the latest approaches in epidemiology, immunology, paediatrics, nutrition, gastroenterology and biostatistics to investigate factors that cause, prevent and improve food allergies and aims to eradicate food allergy through improved prevention and cure, supported by evidence generated by a collaborative network of research; additional aim is to improve management of food allergy through public health policy and clinical pathways.
Top Publications
Balloch, A, Licciardi, PV, Russell, FM, Mulholland, EK, Tang, MLK.
Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine..
J Allergy Clin Immunol
126(2)
:
395 -397
2010
view publication
McKenzie, R, Burton, MD, Royce, SG, Tang, MLK.
Age and sex influences on airway hyperresponsiveness..
J Asthma
47(6)
:
651 -654
2010
view publication
Royce, SG, Lee, M, Tang, MLK.
The contribution of L-selectin to airway hyperresponsiveness in chronic allergic airways disease..
J Asthma Allergy
3:
9 -17
2010
view publication
Licciardi, PV, Balloch, A, Russell, FM, Mulholland, EK, Tang, MLK.
Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization..
Vaccine
28(22)
:
3793 -3800
2010
view publication
Bourke, JE, Ibrahim, A, Tran, J, Royce, S, Tang, MLK, Bailey, S.
Bronchodilator Actions Of Rosiglitazone Are Maintained In Inflamed Airways: Potential Role Of Rho-kinase Inhibition.
a5312 -a5312
2010
view publication